There is no direct dose equivalence between methocarbamol (Robaxin) 1500 mg and cyclobenzaprine (Flexeril)—these medications work differently and cannot be converted on a milligram-to-milligram basis.
Recommended Cyclobenzaprine Dosing
If switching from methocarbamol to cyclobenzaprine, use the standard FDA-approved cyclobenzaprine dose: 5 mg three times daily (TID), which can be increased to 10 mg TID if needed 1. The extended-release formulation is 15-30 mg once daily 1.
Why This Approach
No equivalence exists: Methocarbamol and cyclobenzaprine are different classes of skeletal muscle relaxants with distinct mechanisms of action. Methocarbamol's mechanism is not fully understood, while cyclobenzaprine acts centrally as a muscle relaxant. There is no pharmacologic basis for dose conversion between them.
Start with lower cyclobenzaprine dose: Research demonstrates that cyclobenzaprine 5 mg TID is as effective as 10 mg TID but causes less sedation 2. In two large placebo-controlled trials, the 5 mg dose showed significant improvement in pain relief and function compared to placebo, with better tolerability than the 10 mg dose 2.
Limited duration recommended: Both FDA labels and guidelines recommend using skeletal muscle relaxants for no more than 2-3 weeks 1, 3. Evidence supports efficacy primarily in acute settings (2-4 days to 2 weeks) 4.
Practical Dosing Algorithm
- Start with cyclobenzaprine 5 mg TID (every 8 hours)
- If inadequate relief after 2-3 days, increase to 10 mg TID
- Discontinue after 2-3 weeks maximum
- Take with or without food; can be taken at bedtime if sedation is problematic
Important Caveats
Cyclobenzaprine causes more sedation than methocarbamol: The most common adverse effects are somnolence, dry mouth, dizziness, and fatigue 2, 5. CNS side effects occur in approximately 2x the rate compared to placebo 4.
Limited evidence for superiority over placebo: Recent high-quality ED-based research found that when combined with NSAIDs, cyclobenzaprine provided no additional benefit over placebo for acute low back pain 5. Another 2022 study comparing seven skeletal muscle relaxants found no significant differences between any of them, including cyclobenzaprine and methocarbamol 6.
Safety concern with opioids: If the patient is on concurrent opioids, be aware that cyclobenzaprine is the safest skeletal muscle relaxant in this context—baclofen carries 2.5x higher risk of opioid overdose compared to cyclobenzaprine 7.
Consider whether any muscle relaxant is needed: Given the marginal efficacy demonstrated in recent trials 5, 6, reassess whether continuing muscle relaxant therapy is necessary, particularly if the patient is already on NSAIDs or acetaminophen.